RSS

Tianjin Kinnovata Pharmaceutical Company

Recipharm is working with Vectura Group plc to provide the Chinese regulatory authorities with access to its licence for the regulatory dossier of Asmasal Clickhaler as part of the Chinese market approval process. The regulatory submission will... more

Technology